CU-BX Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

CU-BX General Information

Description

Developer of a health monitoring technology designed to deliver personalized actionable insights that improve quality of life. The company's patented artificial intelligence system offers a clinically validated, contact-free technology that can remotely detect signs of pulmonary congestion in the home, supporting the timely detection of changes in lung fluid content, enabling patients with congestive heart failure and other chronic cardiopulmonary diseases by monitoring their health daily, freeing them to focus on living their life to the fullest and helping to prevent avoidable rehospitalization.

Contact Information

Formerly Known As
ContinUse Biometrics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • HaNechoshet Street 6
  • Tel Aviv 6971070
  • Israel
+972
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Clinics/Outpatient Services
Elder and Disabled Care
Corporate Office
  • HaNechoshet Street 6
  • Tel Aviv 6971070
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CU-BX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Out of Business 01-Feb-2025 Completed Out of Business
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC 01-Oct-2022 Completed Generating Revenue
10. Later Stage VC (Series 1) 14-Dec-2021 Completed Generating Revenue
9. Grant 08-Dec-2021 Completed Generating Revenue
8. Grant 19-Jan-2021 Completed Generating Revenue
7. Accelerator/Incubator 12-Jun-2018 Completed Generating Revenue
6. Later Stage VC (Series B) 08-Mar-2018 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2018 $7.9M Completed Generating Revenue
4. Accelerator/Incubator 01-Dec-2017 $7.9M Completed Generating Revenue
To view CU-BX’s complete valuation and funding history, request access »

CU-BX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B3
Series B2
Series B1
Series A3
Series A2 6,000,000 $0.000100 $0.56 $0.56 1x $0.56 13.64%
Series A1 6,000,000 $0.000100 $0.3 $0.3 1x $0.3 12.63%
To view CU-BX’s complete cap table history, request access »

CU-BX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a health monitoring technology designed to deliver personalized actionable insights that improve quality of
Therapeutic Devices
Tel Aviv, Israel
6 As of 2024

Wexford, PA
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CU-BX Competitors (11)

One of CU-BX’s 11 competitors is Rijuven, a Formerly VC-backed company based in Wexford, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rijuven Formerly VC-backed Wexford, PA
GOQii Venture Capital-Backed Menlo Park, CA
Noom Venture Capital-Backed Princeton, NJ
Endomag Formerly VC-backed Cambridge, United Kingdom
MediPines Venture Capital-Backed Yorba Linda, CA
You’re viewing 5 of 11 competitors. Get the full list »

CU-BX Patents

CU-BX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210172883-A1 System and method for passively monitoring a sample Inactive 05-Dec-2019
JP-2020151474-A System and method for optical monitoring using symmetry condition of light field Pending 19-Mar-2019
US-10861171-B2 System and method for optical monitoring using symmetry condition of light field Inactive 19-Mar-2019
US-20200302620-A1 System and method for optical monitoring using symmetry condition of light field Active 19-Mar-2019
US-20200232915-A1 Speckle based sensing of acoustic excitation in solutions Inactive 22-Jan-2019 G01N29/2418
To view CU-BX’s complete patent history, request access »

CU-BX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CU-BX FAQs

  • When was CU-BX founded?

    CU-BX was founded in 2013.

  • Where is CU-BX headquartered?

    CU-BX is headquartered in Tel Aviv, Israel.

  • What is the size of CU-BX?

    CU-BX has 6 total employees.

  • What industry is CU-BX in?

    CU-BX’s primary industry is Therapeutic Devices.

  • Is CU-BX a private or public company?

    CU-BX is a Private company.

  • What is CU-BX’s current revenue?

    The current revenue for CU-BX is .

  • How much funding has CU-BX raised over time?

    CU-BX has raised $27.4M.

  • Who are CU-BX’s competitors?

    Rijuven, GOQii, Noom, Endomag, and MediPines are some of the 11 competitors of CU-BX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process